Uppsala Reports
Keep up to date with the latest news on safer use of medicines, pharmacovigilance practice, the activities of the WHO Programme and related topics Read more
News
EMA to launch a new, improved EudraVigilance
EMA will launch a new and improved version of EudraVigilance on 22 November 2017 with enhanced functionalities for reporting and analysing suspected adverse reactions. The Agency is delivering training courses on the enhanced EudraVigilance system to support national competent authorities ... Read more
WHO launch Global Patient Safety Challenge
WHO have launched a new global programme which aims to reduce the harm caused by avoidable medication errors. Read more
One Million Visits!
The Global Health Network would like to thank all of the researchers and groups who have made the effort to share their materials
The Global Health Network is celebrating a major milestone in it’s quest to enable life-saving evidence to be gathered in the world’s poorest countries. This is all about a digital platform for medical researchers around the world that is changing ... Read more
Global Pharmacovigilance User Survey
We asked you for your views on this site and what you wanted to see - here are the results!! Read more
ICH Guideline on the Common Technical Document revised
The ICH M4(R4) Guideline reaches Step 4 of the ICH process and now enters the implementation period (step 5)
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) unites regulatory authorities and the pharmaceutical industry to discuss scientific and technical aspects of the drug registration process. Click here to read more about ICH. Read more
WHO African Collaborating Centre for Pharmacovigilance and Guilin Pharma sign deal
The agreement calls for the African Collaborating Centre to undertake worldwide pharmacovigilance of three antimalarials manufactured by Guilin Pharma.
NEW Publication - 'Ethics in epidemics, emergencies and disasters: Research, surveillance and patient care'
The WHO has announced the publication of their latest training manual aimed at health professionals and policy makers working in the context of an emergency situation. Read more
Improving safety of first-in-human clinical trials:
EMA starts EU-wide reflection on necessary changes to best practices
E-Learning
Featured
Global Health Trials
Introduction to Collecting and Reporting Adverse Events in Clinical Research
Featured
Global Health Trials
Data Safety and Monitoring Boards for Clinical Trials
Featured
Global Health Trials
Children and Clinical Research
Articles
Featured
Cochrane Adverse Effects Methods Group Webinar on How to Overcome the Challenge of Reviewing Adverse Effects
The Cochrane Adverse Effects Methods Group (CAEMG), part of the Cochrane Collaboration, aims to inform on and help develop best practice methods for producing high quality systematic reviews, in particular ...
Featured
DSMBs and clinical trial safety
The Data Safety and Monitoring Board (DSMB) or Data Monitoring Committee (DMC – these are synonymous terms) is a group of individuals put together by the sponsor or CRO (if contracted ...
Featured
Malaria in Pregnancy Consortium Safety Tools and Resources
Research in pregnant and breastfeeding women is a complex area, with both the wellbeing of the mother and child paramount. Careful monitoring of any intervention to treat, or prevent, illness ...
Featured
AERSMine - an adverse event data mining tool
A novel application utilising data from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) has been developed by a Biomedical Informatics team at the Cincinnati Children ...
Cups or Cash for Girls (CCg) Trial in Western Kenya
In clinical drug trials, researchers have an obligation to safeguard participants against harms which may be related to the interventional drug, and to ensure the benefit-to-harms ratio remains favourable for ...
EDCTP-AREF Preparatory Fellowships call for applications
AREF-EDCTP have announced a joint call for a Preparatory Fellowship programme, due to be initiated in 2018. The objectives of this call are to: 1 – Enable outstanding African researchers (0 ...
Pharmacovigilance in pregnancy
Pregnant women are largely excluded from clinical trials during drug development, unless the drug is specifically intended for use in pregnancy. Therefore often little is known about the risk of ...
Cochrane Adverse Effects Methods Group Webinar on How to Overcome the Challenge of Reviewing Adverse Effects
The Cochrane Adverse Effects Methods Group (CAEMG), part of the Cochrane Collaboration, aims to inform on and help develop best practice methods for producing high quality systematic reviews, in particular ...
DSMBs and clinical trial safety
The Data Safety and Monitoring Board (DSMB) or Data Monitoring Committee (DMC – these are synonymous terms) is a group of individuals put together by the sponsor or CRO (if contracted ...
Featured
Building Teratovigilance Capacity in Africa
See http://www.buildingteratovigilance.co.za/ for more information and registration
